HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.
发明人:
MICHAL DRANITZKI ELHALEL
申请号：
IL22548813
公开号：
IL225488A
申请日:
2013.03.24
申请国别(地区):
IL
年份:
2017
代理人:
摘要：
Use of a chimeric protein selected from the group consisting of CTLA4-FasL and CD40-FasL proteins for treatment of lymphoma and/or a multiple myeloma and/or a leukemia as described herein, and pharmaceutical compositions and methods of treatment thereof.
